Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Shares Outstanding (Diluted Average) (2023 - 2026)

BioAge Labs' Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $35.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 234.99% to $35.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.9 million, a 234.99% increase, with the full-year FY2025 number at $35.9 million, up 234.99% from a year prior.
  • Shares Outstanding (Diluted Average) hit $35.9 million in Q4 2025 for BioAge Labs, roughly flat from $35.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for BIOA hit a ceiling of $35.9 million in Q4 2025 and a floor of $1.7 million in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $18.0 million across 3 years, with a median of $10.7 million in 2024.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 2042.25% in 2025, down 234.99% in 2025.
  • Tracing BIOA's Shares Outstanding (Diluted Average) over 3 years: stood at $1.7 million in 2023, then skyrocketed by 541.23% to $10.7 million in 2024, then surged by 234.99% to $35.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for BIOA at $35.9 million in Q4 2025, $35.9 million in Q3 2025, and $35.9 million in Q2 2025.